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Experimental part 
Solution studies 
All NMR spectral measurements were performed on a Bruker Avance III 500 spectrometer 
equipped with a broad-band direct probe. The spectra were recorded at room temperature in 
DMSO-d6. Chemical shifts are given on  scale relative to tetramethylsilane as internal 
standard for 
1
H and 
13
C or Cd(ClO4)2 in D2O as external standard for 
113
Cd. Coupling 
constants (J) were expressed in Hz. Abbreviations used for NMR spectra: s, singlet; d, 
doublet; t, triplet; br. broad. 1D and 2D spectra are shown in Figures S2–S11. UV-visible 
(UV-Vis) spectrum was recorded on a GBC Scientific Cintra 6 UV-Vis spectrophotometer 
(200-1000 nm), using sample dissolved in DMSO (Figures S12). 
Calculation of electronic spectral data 
The Gaussian 09 program suite [S1] was used for the quantum mechanical computations.  
Molecular structures were optimized using density functional theory (DFT) approach, with 
B3LYP [S2,S3] functional in the gas phase, and re-optimized in dimethyl sulfoxide (DMSO) 
solvent, stimulated by the universal solvation model (SMD) [S4]. The cadmium ion was 
described using the lanl2dz  EPC [S5] and for all other atoms 6-31G(d,p) [S6,S7] basis sets 
were applied. The calculations were performed under restricted formalism, using tight 
convergence criteria, without any symmetry constraints and all the ground state geometries 
were verified by frequency calculations. To obtain the calculated UV-Vis spectra (Figure 
S13), the time dependent density functional theory (TD-DFT) calculation was performed, 
using the same functional, the basis sets and the solvent. The single crystal structure of 1 was 
used as starting geometries for theoretical calculations. Also, the several species, potentially 
present in DMSO solution, has been considered (Figure S13). 
Anticancer experiments 
Cell cultures 
Human mammary adenocarcinoma (MCF-7, ATCC® HTB-22) and human pancreatic 
adenocarcinoma (AsPC-1, ATCC® CRL-1682) cell lines were maintained in DMEM high 
glucose medium (Dominique Dutscher, 67172 Brumath cedex, France, Cat No L0102-500), 
supplemented with 10% (v/v) heat inactivated fetal bovine serum (FBS, Life Technologies, 
Paisley, UK, Cat No 10270-106) and 1% (v/v) penicillin-streptomycin (10,000 units/mL and 
4 
 
10,000 µg/mL, Life Technologies, Paisley, UK, Cat No 15140-122). Cells were kept at 37 ºC 
in humidified atmosphere containing 5% (v/v) CO2 during their exponential growing phase 
and in the course of incubation with investigated compounds.  
Complex 1 was initially dissolved in dimethyl sulfoxide (DMSO) as 20 mM stock 
solution. Further dilutions applied in cell experiments have been done in DMEM just before 
each use, with a final concentration of DMSO never exciding 0.5% (v/v). CDDP was 
dissolved in phosphate buffer solution (PBS) while its further dilutions have been made in 
DMEM. 
 
Annexin V and propidium iodide (PI) staining 
Cells were seeded in 96 wells flat bottom plates (Corning® Costar®, Cat. No. 
CLS3596) in 0.1 mL, at a density of 10 000/well and left overnight. Investigated compounds 
were added in a range of six concentrations. As controls, non-treated cells, cells treated with 
0.5% DMSO, and cells treated with Celastrol (Enzo Life Sciences, Cat. No. ALX-350-332-
M025) at 50 µM concentration were used.  
After 24 h of incubation, AsPC-1 and MCF-7 supernatant non-adherent cells were 
transferred into another 96 well plate. For the remaining adherent cells, 200 µL of 2 mM 
EDTA in 0.9% NaCl was added and plates have been left for 15 min at 37 °C. EDTA solution 
was discarded after plates were centrifuged at a relative centrifugal force (RCF) 450×g for 10 
min, then 200 µL of trypsin-EDTA (BioWest, Nuaille, France, Cat No L0930-100) was 
added to each well.  Plates were incubated for 15 min at 37 °C and supernatants were 
removed after additional spinning cycle. Previously removed supernatants with non-adherent 
cells were returned to detached cells and stained with Annexin V-FITC (Immuno Tools, 
Friesoythe, Germany, Cat No 31490013) and propidium iodide (PI, Miltenyl Biotec Inc, 
Auburn, USA, Cat No 130-093-233) in a volume of 3 µL. Described trypsinization protocol 
was applied each time AsPC-1 and MCF-7 cells were prepared for flow cytometry analysis, 
unless is stated otherwise.  
Cells were analyzed on Guava® easyCyte 12HT Benchtop flow microcapillary 
cytometer using the dedicated InCyte® software package. Cells were classified according to 
AnnexinV-FITC (green fluorescence) and PI (red fluorescence) labelling on viable (double 
negative), pre-apoptotic (Annexin V-FITC single-stained cells), necrotic (PI single-stained 
cells) and advanced phases of apoptosis (double-stained cells).  
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Calculation of ApoC50 concentration 
Percentages of Annexin V single-stained and double-stained cells were summarized 
for each concentration of investigated compound. The computed percentages were charted 
against corresponding concentrations and ApoC50 concentration was computed as the one that 
corresponds to 50 % of whole apoptotic events (early and late apoptosis) on the 
concentration-response curve (Figure S15). Concentration-effect curves have been plotted 
using asymmetric five-parameter logistic equation (GraphPad Prism 6 software). 
 
Cell cycle analysis 
Distribution of cells within phases of mitotic division has been evaluated on 
remaining cells after Annexin V/PI analysis, which right after the read out was finished were 
fixed in ethanol and left overnight at 4 °C. Before reading, plates were centrifuged at an RCF 
450×g for 10 min, ethanol was discarded, and PBS added in a volume of 100 µL per well. 
Cells were stained with 50 µL of FxCycle
TM
 PI/RNAse Staining solution (Molecular Probes, 
Cat. No. F10797) and incubated at 37 °C for 30 min. Plates were analyzed on Guava® 
easyCyte 12HT Benchtop flow microcapillary cytometer using the dedicated InCyte® 
software package. 
 
Inhibition of caspase activity 
Cells were treated with investigated compounds at its ApoC50 concentration for 6 h 
with or without pan-caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoro 
methylketone (Z-VAD-fmk), Promega, Madison, USA, Cat. No. G7232). Z-VAD-fmk was 
added in a concentration that was previously tested and confirmed as non-toxic to cells over 6 
h incubation (20 µM for AsPC-1 and MCF-7 cell lines, respectively). As controls, non-
treated cells, cells treated with Z-VAD-fmk only, and cells treated with investigated 
compound only were used. After incubation period was ended, treated cells were carried out 
for Annexin V/PI staining as described above, and analyzed on Guava® easyCyte 12HT 
Benchtop flow microcapillary cytometer using the dedicated InCyte® software package. 
The percent of apoptosis inhibited by Z-VAD-fmk co-treatment was determined using 
equation (S1): 
Apoptosis inhibition (%) = [1 – (% of apoptosis in A / % of apoptosis in B)] × 100        (S1) 
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where A is the sample treated with Z-VAD-fmk and investigated compound at its ApoC50 
concentration, while B is the corresponding sample treated only with the same investigated 
compound applied at the same concentration. 
 
Evaluation of caspase-8 and -9 activities 
Cells were treated with investigated compound at its ApoC50 concentration for 6 h. 
Following trypsinization activities of caspase-8 and -9 were assayed by means of Guava 
Caspase 9 SR and Caspase 8 FAM kit (EMD Millipore, Cat. No. 4500-0640) following 
manufacturer’s instructions. Cells were analyzed on Guava® easyCyte 12HT Benchtop flow 
microcapillary cytometer using the dedicated InCyte® software package.  
 
Determination of mitochondrial superoxide generation 
Cells were treated over 6 h with investigated compounds in a concentration of 50 µM 
(MCF-7 cells) or 75 µM (AsPC-1 cells), afterwards cell were trypsinized and stained with 
MitoSox Red (Molecular Probes, Cat. No. M36008) according to manufacturer’s 
recommendations. Analysis was performed on Guava® easyCyte 12HT Benchtop flow 
microcapillary cytometer using the dedicated InCyte® software package. 
 
Assessment of changes in mitochondrial potential 
Cells were treated over 6 h with investigated compound in concentration of 50 µM 
(MCF-7 cells) or 75 µM (AsPC-1 cells). After incubation was terminated, cells were 
trypsinized and stained with FlowCellectTM MitoDamage Kit (Merck Millipore Corporation, 
Darmstadt, Germany, Cat. No. FCCH100106) according to manufacturer’s recommendations. 
Analysis has been performed Guava® easyCyte 12HT Benchtop flow microcapillary 
cytometer using the dedicated InCyte® software package. Cells were classified according to 
labeling with Annexin V-FITC (Grn-B fluorescence), MitoSense Red (Red-R fluorescence), 
and 7-Aminoactinomycin D (7-AAD; Red-B fluorescence). 
 
Growth inhibition of 3D tumor models 
Three-dimensional AsPC-1 and MCF-7 tumor models were made in 96 well plates 
(Corning, Sigma-Aldrich, St. Louis, Mo, USA, Cat No 4515). Tumors were left to grow for 
additional four days, afterwards investigated compounds were added in concentrations of 
100, 10, and 1 µM. Evaluation has been maintained during 8-day incubation period, with 
media exchanged on day 4. Changes in the tumor sizes have been assessed on Celigo
®
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imaging cytometer (Cyntellect, Brooks Life Science Systems, Poway, CA, USA) using 
Celigo software. Growth rates of non-treated and treated spheroids were computed for every 
other day during 8-day incubation by dividing the area on the day n with the area on the day 
0. 
 
DNA binding experiments 
Agarose gel electrophoresis 
Plasmid pUC19 (2686 bp in length, purchased from Sigma-Aldrich, USA) was prepared by 
its transformation in chemically competent cells Escherichia coli (E. coli) strain XL1 blue. 
Amplification of the clone was done according to the protocol for growing E. coli culture 
overnight in LB medium at 37 °C  [S8] and purification was performed using Qiagen Plasmid 
plus Maxi kit. Finally, DNA was eluted in 10 mM Tris-HCl buffer and stored at  
−20 °C. The concentration of plasmid DNA (0.512 µg/µL) was determined by measuring the 
absorbance of the DNA-containing solution at 260 nm. One optical unit corresponds to 50 µg 
mL
−1
 of double stranded DNA. 
Plasmid DNA (0.5 µg) was incubated with increasing volumes of stock solution of 1 
(1, 2, 3 and 4 µL) in a 20 µL reaction mixture in 40 mM bicarbonate buffer (pH 8.4) at 37 °C, 
for 90 min. The reaction mixtures were vortexed from time to time. The reaction was 
terminated by short centrifugation at an RCF 6708×g and addition of 5 µL of loading buffer 
(0.25% bromophenol blue, 0.25% xylene cyanol FF and 30% glycerol in TAE buffer: 40 mM 
Tris-acetate, 1 mM EDTA, pH 8.24).  
The samples were subjected to electrophoresis on 1% agarose gel (Amersham 
Pharmacia-Biotech, Inc) prepared in Tris acetate-EDTA buffer pH 8.24. The electrophoresis 
was performed at a constant voltage (80 V) until bromophenol blue had passed through 75% 
of the gel. A Submarine Mini-gel Electrophoresis Unit (Hoeffer HE 33) with an EPS 300 
power supply was used. After electrophoresis, the gel was stained for 30 min by soaking it in 
an aqueous ethidium bromide (EB) solution (0.5 µg mL
−1
). The stained gel was illuminated 
under a UV transilluminator Vilber-Lourmat (France) at 312 nm and photographed with a 
Nikon Coolpix P340 Digital Camera through filter DEEP YELLOW 15 (TIFFEN, USA). 
Fluorescence measurements 
Calf thymus DNA (lyophilized, highly polymerized, obtained from Serva, Heidelberg) (CT-
DNA) was dissolved in Tris buffer (10 mM Tris-HCl, pH 7.9) overnight at 4 °C. This stock 
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solution was stored at 4 °C and was stable for several days. A solution of CT-DNA in water 
gave a ratio of UV absorbance at 260 and 280 nm, A260/A280 of 1.89–2.01, indicating that 
DNA was sufficiently free of protein. The concentration of DNA (2.86 mg mL
−1
) was 
determined from the UV absorbance at 260 nm using the extinction coefficient ε260 = 6600 
M
−1
 cm
−1
 [S9]. Compound 1 was dissolved in DMSO in concentration of 10 mM. This 
solution was used as stock solution. 
The competitive interactions of 1 and the fluorescence probe either EB or Hoechst 
33258 dye (H), with CT-DNA have been studied by measuring the change of fluorescence 
intensity of the probe−DNA solution after addition of 1. Reaction mixtures containing 100 
µM of CT-DNA (calculated per phosphate) in 1 mL of 40 mM bicarbonate solution (pH 8.4) 
were pre-treated with 1.5 µL of 1% H probe solution (28 µM final concentration) or 1 µL of 
1% EB solution (25 µM final concentration) in separate experiments for 20 min and the 
mixture was analysed by fluorescence measurement. Then the increasing concentrations of 1 
were successively added and the changes in the fluorescence intensity were measured using a 
Thermo Scientific Lumina Fluorescence spectrometer (Finland) equipped with a 150 W 
Xenon lamp. The slits on the excitation and emission beams were fixed at 10 nm. All 
measurements were performed by excitation at 350 nm for H dye in the range of 390−550 
nm, and by excitation at 500 nm for EB in the range of 520−700 nm. The control was 
probe−CT-DNA solution. Complex 1 did not have fluorescence under applied conditions. 
The obtained fluorescence quenching data were analysed according to the Stern–Volmer 
equation (S2) [S10]: 
I0/I = 1 + K[1]/[CT-DNA]       (S2) 
where I0 and I represent the fluorescence intensities of probe−CT-DNA in absence and 
presence of 1, respectively, K is quenching constant. The K value is calculated from the ratio 
of the slope to the intercept from the plot of I0/I versus [1]/[CT-DNA]. 
Primary spectra were imported into OriginPro 9.0 and were processed by this software 
package. 
Human serum albumin (HSA) interaction experiments 
A stock solution of fatty acid-free HSA (<0.007 % fatty acids, Mw = 66478 Da, Sigma; c = 
1.63  × 10
–4
 M) was prepared by dissolving accurate weighted mass of HSA in freshly 
prepared PBS (30 mM, I = 0.15 M, pH 7.38). Millipore water was used in the preparation of 
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buffer solution. The stock solutions of 1 (c = 4.42 × 10
-4
 M) was prepared by dissolving the 
necessary amount of solid in DMSO, because of their low solubility in the buffer.  For HSA-
compound interaction studies, HSA solution was freshly prepared from the stock by dilution 
with a buffer (HSA concentration was kept constant, c = 5 × 10
–7
 M), and titrated with a 
compound stock solution to avoid large sample dilution. After each aliquot addition, the 
system was stirred and left to equilibrate for 20 min before UV-Vis absorption and 
fluorescence emission spectra recording.  
Fluorescence measurements were performed on spectrofluorometer Fluoromax-4 
Jobin Yvon (Horiba Scientific, Japan), equipped with Peltier element for temperature control 
and magnetic stirrer for cuvette, using quartz cell with 1 cm path length and 4 mL volume. 
Before the recording of the fluorescence spectrum, diluted HSA solution was filtrated using 
PVDF filters with 0.22 µm pore size. The temperature was kept fixed at 25 °C. An excitation 
wavelength was 280 nm, with 5 nm slits; emission spectra were recorded in 300–500 nm 
wavelength range, with 5 nm slits, and 0.1 s integration time. Background PBS signal was 
subtracted from each spectrum. 
UV/Vis spectra were recorded on GBC Cintra 6 spectrophotometer (GBC 
Dandenong,  Australia)  using quartz cell with 1 cm path length and 4 mL volume. All 
spectra were recorded against the corresponding blank (1% DMSO in PBS) in the 220–550 
nm wavelength range, with 500 nm/min scan speed. 
Acute lethality assay 
Artemia salina toxicity assay was conducted as described earlier [S11]. DMSO was used as 
both, initial solvent and negative control (0.25% v/v), while CDDP was used as positive 
control.  For each concentration of the tested substances two measurements were performed. 
LC50 was defined as the concentration of a substance that causes death of 50% nauplii. 
DMSO was inactive under the applied conditions. 
Molecular docking to HSA and DNA 
The initial coordinates of 1 were taken from the experimentally determined crystal 
structure. Charges were assigned to all ligand atoms using semi-empirical PM6 method 
implemented in MOPAC2016 [S12, S13]. The affinity of 1 to three most common HSA 
binding sites was evaluated by taking the crystal structures of HSA co-crystallized with 
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ligands. The binding sites were defined selecting all amino acid residues in a radius of 12 Å 
around ligand and removal of ligand to make the room for docking of 1. For binding to HSA 
site IB, the crystal structure of idarubicin complex was used (PDB code 4LB2). For binding 
site IIA, a complex of HSA with indolamide derivative was used (PDB code 3LU7). 
Diflunisal co-crystallized with HSA (PDB code 2BXE) was used for assessing the affinity of 
1 toward binding site IIIA.  
The high-resolution DNA duplex sequence d(CGCGAATTCGCG)2 (PDB code: 
3U2N) was chosen for docking of 1 into the DNA. All ligands and water molecules were 
removed and the large box size was chosen, leaving the possibility for docking of 1 into both 
the major and minor DNA groove. 
PLANTS (Protein-Ligand ANT System) [S14, S15] software was used for docking of 
compound 1 to HSA and DNA. The binding affinity was assessed using ChemPLP scoring 
function [S16]. Ten docking solutions were calculated for each binding site of HSA. For 
DNA binding, 20 best poses were selected and analyzed. Vega ZZ 3.1.0  [S17] was used as 
GUI for all calculations. 
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Figure S1. IR spectrum of 1. 
 
 
12 
 
 
 
Figure S2. 
1
H NMR spectrum of 1 in DMSO-d6 (top and middle) and superimposed 
spectrum of 
1
H NMR spectra (bottom) of freshly prepared solution of 1 (red) and after 48 h 
(blue). 
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Figure S3. 
13
C
 
NMR spectrum of 1 in DMSO-d6. 
 
Figure S4. 
113
Cd NMR spectrum of 1 in DMSO-d6 
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Figure S5. COSY spectrum of 1 in DMSO-d6. 
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Figure S6. NOESY spectrum of 1 in DMSO-d6 
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Figure S7. 
1
H–13C HSQC NMR spectrum of 1 in DMSO-d6. 
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Figure S8. 
1
H–13C HMBC NMR spectrum of 1 in DMSO-d6. 
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 Figure S9. 
1
H–15N HSQC NMR spectrum of 1 in DMSO-d6. 
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Figure S10. 
1
H–15N HMBC NMR spectrum of 1 in DMSO-d6. 
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Figure S11. 
1
H NMR spectrum of 1 in DMSO-d6 with addition of 5 % (v) DMSO (top) and 
superimposed spectra of freshly prepared sample and sample after 24 h (bottom). 
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Figure S12. UV-Vis spectrum of 1 in DMSO 
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Figure S13. Calculated UV-Vis spectra for several species that can exist in DMSO solution 
of 1: free aphaOMe ligand (A), binuclear complex 1 (B) and mononuclear pentacoordinated 
Cd(II) complex (C). 
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Figure S14. Optimized geometries of investigated Cd-species with calculated molecular 
orbitals composition:  binuclear complex 1 (A) and mononuclear pentacoordinated Cd(II) 
monomer (B) , in DMSO solvent. 
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Figure S15. Concentration-response curves for investigated compounds. 
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Figure S16. Agarose gel electrophoresis of reaction of pUC19 by 1. The reaction was 
investigated by incubation for 90 min of 0.5 µg plasmid in 20 µL of 40 mM bicarbonate 
buffer pH 8.4 at 37 °C, with different concentrations of the complex. Lane 1 – control 
plasmid; lanes 2, 3, 4, and 5: plasmid with 0.015, 0.02, 0.03 and 0.04 mM concentration of 1, 
respectively. 
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Figure S17. S-V plot for binding of 1 to HSA (c = 5 × 10
–7
 M) at 25 °C. Addition of 1 in 
concentration range from 0 to 4.5 × 10
–6
 M; pH = 7.35 (PBS). 
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Figure S18. Modified S-V plot for binding of 1 to HSA at 25 °C;  
c (HSA) = 5 × 10
–7
 M, c (1)  = 0.0 –4.5 × 10-6 M; pH = 7.35 (PBS). 
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Table S1. Interaction energies based on CE-HF energy model. 
Cg···Cg
a
 / Å Symmetry operation
b 
Interaction energies
c
, kJ mol
−1
 
Eele Epol Edisp Erep Etot 
8.98 x+1, y, z −105.1 −34.5 −97.8 74.1 −157.6 
8.98 x−1, y, z −105.1 −34.5 −97.8 74.1 −157.6 
10.12 −x+5/2, y+1/2, −z+3/2 −62.9 −25.1 −60.9 43.5 −100.0 
10.12 −x+5/2, y−1/2, −z+3/2 −62.9 −25.1 −60.9 43.5 −100.0 
10.12 −x+3/2, y+1/2, −z+1/2 −62.9 −25.1 −60.9 43.5 −100.0 
10.12 −x+3/2, y−1/2, −z+1/2 −62.9 −25.1 −60.9 43.5 −100.0 
13.16 x, y+1, z 3.0 −0.8 −19.4 7.9 −8.6 
13.16 x, y−1, z 3.0 −0.8 −19.4 7.9 −8.6 
10.89 −x+3/2, y+1/2, −z+3/2 5.5 −3.9 −11.9 3.5 −4.8 
10.89 −x+3/2, y−1/2, −z+3/2 5.5 −3.9 −11.9 3.5 −4.8 
10.89 −x+5/2, y+1/2, −z+1/2 5.5 −3.9 −11.9 3.5 −4.8 
10.89 −x+5/2, y−1/2, −z+1/2 5.5 −3.9 −11.9 3.5 −4.8 
15.74 −x+1/2, y+1/2, −z+1/2 4.1 −0.9 −5.0 0.8 −0.2 
15.74 −x+1/2, y−1/2, −z+1/2 4.1 −0.9 −5.0 0.8 −0.2 
15.74 −x+7/2, y+1/2, −z+3/2 4.1 −0.9 −5.0 0.8 −0.2 
15.74 −x+7/2, y−1/2, −z+3/2 4.1 −0.9 −5.0 0.8 −0.2 
13.72 x, y, z+1 0.7 −0.6 −8.2 9.0 0.3 
13.72 x, y, z−1 0.7 −0.6 −8.2 9.0 0.3 
a
Cg···Cg is the distance between centroids of the two interacting dimers.  
b
Symmetry operations given generate only half of the interacting molecule, as they are related to the 
asymmetric unit.  
c
Total energies for CE-HF benchmarked energy model (based on HF/3-21G monomer electron 
densities) are the sum of the four energy components, scaled appropriately:  
Etot = keleEele + kpolEpol + kdispEdisp + krepErep. Scale factor have values: kele = 1.019, kpol = 0.651,  
kdisp = 0.901, krep = 0.811.  
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Table S2. ChemPLP docking score of for binding of 1 to the DNA and HSA three binding 
sites  
Binding site (PDB code) ChemPLP docking score (TOTAL_SCORE) 
IB (4LB2) –80.72 
IIA (3LU7) –83.50 
IIIA (2BXE) –81.09 
DNA (3U2N) –52.66 
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